Introduction
Gadolinium (Gd)-based contrast agents have been used to measure blood volume and flow using T * 2 -weighted dynamic imaging [1] or vascular leakiness and its associated tissue microcirculation properties using T 1 -weighted dynamic imaging [2] . In T 1 -weighted dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), it is typically assumed that T * 2 has a negligible effect on the data. This assumption may be valid in general as most DCE-MRI scan protocols employ minimal echo times around 1-3 ms [3] [4] [5] . When the T * 2 effect is negligible, the conversion of time-intensity curves to time-concentration curves is simplified, as the signal enhancement depends only on changes in T 1 induced by contrast agent concentration. However, a recent study [6] has demonstrated that the T * 2 effect may not be negligible in practice. The influence of the T * 2 effect on T 1 -weighted DCE-MRI data can be more pronounced at a high magnetic field strength, such as 7 T, as the T * 2 of tissue becomes shorter with the increase of field strength. It has also been recently shown that, even at 3T, which is widely used for routine clinical imaging, the effect of T * 2 cannot be ignored [6] . An arterial input function (AIF) measured from a major vessel could be substantially underestimated due to larger T * 2 effects from higher concentrations of contrast agent. In contrast, the T * 2 effect on a lesion signal intensity curve should be relatively less, due to its lower contrast agent concentration compared to that in the plasma. This difference in T * 2 effect between the lesion and plasma results in over-estimation of the contrast kinetic model parameters.
Abstract
Objectives We aimed to investigate the effect of T * 2 correction on estimation of kinetic parameters from T 1 -weighted dynamic contrast enhanced (DCE) MRI data when a reference-tissue arterial input function (AIF) is used. Materials and methods DCE-MRI data were acquired from seven mice with 4T1 mouse mammary tumors using a double gradient echo sequence at 7 T. The AIF was estimated from a region of interest in the muscle. The extended Tofts model was used to estimate pharmacokinetic parameters in the enhancing part of the tumor, with and without T * 2 correction of the lesion and AIF. The parameters estimated with T * 2 correction of both the AIF and lesion time-intensity curve were assumed to be the reference standard. Results For the whole population, there was significant difference (p < 0.05) in transfer constant (K trans ) between T * 2 corrected and not corrected methods, but not in interstitial volume fraction (v e ). Individually, no significant differences were found in K trans and v e of four and six tumors, respectively, between the T * 2 corrected and not corrected methods. In contrast, K trans was significantly underestimated, if the T * 2 correction was not used, in other tumors for which the median K trans was larger than 0.4 min −1 . Conclusion T * 2 effect on tumors with high K trans may not be negligible in kinetic model analysis, even if AIF is estimated from reference tissue where the concentration of contrast agent is relatively low.
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The decrease in T 1 -weighted signal intensity due to the T * 2 effect can be corrected by measuring T * 2 using multiple echoes per excitation [7, 8] . While this method can directly correct for the T * 2 effect, it results in a lower temporal resolution due to an increased repetition time (TR) and can be more sensitive to noise as T * 2 becomes short. Alternatively, the T * 2 effect on the AIF can be reduced by using two injections of contrast agent at half dose with a sufficient delay between the injections to keep their peak enhancements well separated [9] . Another possibility is to estimate AIF from a reference tissue, such as muscle [10] . Since the contrast agent concentration in muscle tissue is not as high as in an artery, we expect the T * 2 effect to be smaller for a reference tissue AIF than for a directly measured AIF. However, it has not been shown to date how T * 2 variation following contrast agent injection affects DCE-MRI kinetic model analysis with a reference tissue AIF.
The aims of this study were to investigate the effect of T * 2 changes on (1) the reference tissue AIF estimated from muscle, where Gd concentration remains relatively low, and (2) the contrast kinetic model parameters of tumors when using a reference tissue AIF.
Materials and methods

Animal model
Six-week-old to eight-week-old BALB/c mice (n = 7) were given a subcutaneous injection of 1 × 10 5 4T1 mouse mammary tumor cells, suspended in 0.1 mL of phosphatebuffered saline, in the right flank. All mice were scanned between post-injection days 10 and 13 when the longest diameter of the tumor was approximately 10 mm. For MRI scans, general anesthesia was induced by 1.5 % isoflurane in air. The animal was mounted on a cradle with respiratory and temperature monitoring probes. The animal body temperature was maintained at 33 ± 2 °C during the scan. All mice were treated in strict accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and this study was approved by the Institutional Animal Care and Use Committee.
Data acquisition
MRI experiments were performed on a 7 T micro-MRI system, consisting of a Biospec Avance II console (Bruker Biospin MRI, Ettlingen, Germany) interfaced to a 200-mm horizontal bore magnet (Magnex Scientific, Yarnton, Kidlington, Oxfordshire, UK) with an actively shielded gradient coil (Bruker, BGA-95; gradient strength, 750 mT m −1 ). A quadrature Litz coil [42 mm (length) × 38 mm (diameter), Doty Scientific, Columbia, SC, USA] was used to image the animal while mounted on a cradle with respiratory and temperature monitoring probes.
Before injection of the contrast agent, measurement of T 1 was performed using an inversion recovery pulse sequence with TR/TE = 12 s/3.82 ms and inversion times of 0.05, 0.5, 2.5 and 5 s. The dynamic study was performed using a three-dimensional (3D) multiple spoiled gradient echo sequence in steady state with Cartesian K-space sampling and no parallel imaging. Scan parameters were TR/TE 1 /TE 2 = 12/2.593/6.793 ms, flip angle (α) = 15°, acquisition matrix = 128 × 72 × 9, reconstructed image matrix = 128 × 128 × 9, resolution = 0.25 × 0.25 × 2 mm 3 , temporal resolution = 7.8 s. The first echo was the shortest echo time allowed in the product sequence. This sequence was run to acquire 60 3D images in about 8 min. A bolus of 10 mM Gd-DTPA in phosphate buffered saline, corresponding to a dose of 0.2 mmol kg −1 , was injected through a tail vein catheter 1 min after the start of data acquisition.
Data analysis
The spoiled gradient echo signal is modeled as the following [11] :
where S 0 represents the relaxed signal for a 90° pulse when TR ≫ 1/R 1 (t), α is the flip angle, and R 1 (t) is the apparent longitudinal relaxation rate depending on the concentration of contrast agent in the tissue at time t. T * 2 values of individual voxels at each time point were estimated from the double-echo data;
where S TE 1 (t) and S TE 2 (t) are the spoiled gradient echo signal intensities measured at the two echo times, TE 1 and TE 2 , respectively. We used S TE 1 (t) as the uncorrected time-intensity curve (TIC) and S ′ TE 1
without the T * 2 decay term. The signal enhancement by contrast agent can be expressed as a ratio between S TE (t) and S TE (0), which eliminates S 0 and the T * 2 decay term, and makes it possible to estimate R 1 (t) from the measured data. Indirect estimation of the CR concentration can be made from the estimated
. We assumed the fast exchange limit and use a linear relationship between the contrast agent concentration C(t) and R 1 (t):
where R 10 is the longitudinal relaxation rate of tissue before contrast injection, and r 1 is the contrast agent relaxivity [11] .
The AIF was estimated using the muscle as a reference region [10] . The Gd concentration in the plasma, C p (t), was estimated from either T * 2 corrected or uncorrected data of the reference region tissue, C t (t), using the following equation [12] :
where the reference muscle transfer constant, K trans , and interstitial volume fraction, v e , were assumed to be 0.11 min −1 and 0.15, respectively [10] . In order to minimize the effect of the noise, a multiple layer feed-forward back propagation neural network (two hidden layers with two neurons in each hidden layer) was used to estimate a smoothed tissue concentration curve [13] . The extended Tofts model [14] with a vascular compartment was used for contrast kinetic model analysis to obtain the transfer constant (K trans ), interstitial volume fraction (v e ), and vascular plasma volume fraction (v p ). The model was fitted to either T * 2 corrected or uncorrected lesion TIC (LTIC) by minimizing the sum of squares of the difference using the Simplex [15] method provided in Matlab (MathWorks, Natick, MA).
Since T * 2 correction can be applied to the AIF and/or the LTIC, there are four different methods of T * 2 correction included in this study: (I) both AIF and LTIC corrected; (II) no correction; (III) only AIF corrected; (IV) only LTIC corrected. The kinetic parameters estimated using method I were assumed to be the most accurate and were used as the reference standard for comparison with the other T * 2 correction methods. The correction methods III and IV were used to assess how much impact there is by correction of either AIF or LTIC alone. Contrast kinetic model analysis was performed on a voxel-by-voxel basis, unless otherwise stated. Wilcoxon rank sum test was used to assess differences between kinetic parameters estimated in using the different T * 2 correction methods. A paired t test was used to compare goodness of fit between data from two different correction methods. The effect of AIF T * 2 correction on goodness of fit was assessed to examine whether a poor fit could have affected the comparisons between contrast kinetic parameters from different T * 2 correction methods.
Results Figure 1a shows an example of a post-contrast T 1 -weighted image with regions of interest (ROI) indicated for the
muscle and the enhancing part of the lesion. The ROIs were selected using a post contrast image. Tumor vessels were not segmented out due to a relatively low spatial resolution of our DCE-MRI protocol. The corresponding T * 2 maps of the same slice in Fig. 1a are shown for three different time points (baseline, peak, and washout) in Fig. 1b . It is apparent from Fig. 1c that T * 2 values near the peak are shorter than at baseline or washout for the ROIs of the muscle and enhancing portion of the tumor. It is shown in Fig. 1c that the T * 2 effect has a higher impact for the lesion (the T * 2 value dropped from about 12 ms at baseline to 6 ms at peak; the equivalent R * 2 change is 83 s −1 ) than the muscle (about 7 ms at baseline to 5 ms at peak; the equivalent R * 2 change is 57 s ), which indicates high vascularity and/or vascular leakiness of the lesion [16] . Figure 1d shows S TE 1 (t) and S TE 2 (t) of the muscle ROI along with T * 2 -corrected TIC, S ′ TE 1 (t). Figure 1e shows the AIFs estimated from S TE 1 (t) and S ′ TE 1 (t) of the muscle reference region shown in Fig. 1d . The corrected AIF cannot be achieved by a linear scaling of non-corrected AIF based on the area under curve or the peak magnitude; they have shapes of different curve patterns. This demonstrates that T * 2 correction of the muscle signal results in a substantial increase in the estimated AIF. A similar effect has been seen when T * 2 correction is applied directly to the plasma signal [6] . Figure 1f shows that the example model fits to the T * 2 corrected and uncorrected LTIC.
Representative examples of kinetic model parameter maps are shown in Fig. 2a, b for the mouse presented in Fig. 1 . The parameter maps of Method I (both AIF and LTIC corrected) appear similar to those of Method II (no correction) more than those of Methods III and IV. The parameter maps of Method III (only AIF corrected) show noticeably lower K trans and v e than those of Methods I and II, whereas Method IV (only LTIC corrected) maps show higher K trans and v e values in general than those of Methods I and II. There was no remarkable difference in v p estimates for the particular case shown in Fig. 2 . The differences between the K trans values for different correction methods for pixels in the enhancing rim increases as the reference standard (Method I) K trans increases (Fig. 2c) . However, the differences correspond to similar percentage changes, as shown in the relative error plot (see (f) Fig. 1 Representative case demonstrating T * 2 correction using double gradient echo data. a Axial slice with ROIs for reference muscle (white) and enhancing lesion rim (red). b T * 2 maps estimated at different times; baseline (30 s before injection), near-peak (100 s) and washout (400 s), red and white ROIs are the same as (a). c Average T * 2 curves from the muscle (blue) and lesion (black). d Average signal intensity curves from the muscle; thin solid line for echo 1, thin dashed line for echo 2 and thick solid line for T * 2 corrected echo 1 data. e AIF generated from corrected echo-1 data (thick red solid) and uncorrected echo-1 data (thin red solid) from the reference region. f Lesion enhancement curves from echo 1 (thin black solid), echo 2 (thin black dash) and T * 2 corrected echo 1 (thick black solid), and the corresponding model fit for echo 1 (thin green solid) and corrected echo 1 (thick green solid) data have negative trends; the higher the mean values are, the bigger the degree of underestimation in terms of all three parameters (Fig. 4a, b) . The v e estimates of Method II appear to have a less obvious trend (regression line slope is −0.03 compared with −0.24 for Method III and 0.21 for Method IV). In contrast, Method IV data show positive trends; the higher the mean values, the larger the degree of overestimation in all three parameters. For the whole voxels pooled from all enhancing tumor regions, there was significant difference (p < 0.05) in K trans between T * 2 corrected and not corrected methods, but not in v e .
The effect of T * 2 correction observed in this study is summarized in Fig. 5 using median relative errors in K trans and v e values from lesions in the individual animals. Method II parameters are distributed closest to the origin (i.e., Method I). Method III parameters are in the lower left quadrant indicating under-estimation of both K trans and v e , whereas the Method IV parameters in the upper right quadrant demonstrate over-estimation of both parameters.
Goodness of fit was evaluated with a paired t test. Method I was tested against Method IV and Method II was tested against Method III, as the same LTIC curves are used in each pair; the LTIC is corrected in Methods I and IV, and not corrected in Methods II and III. Among all 14 comparisons, only one case showed a significant difference in terms of goodness of fit (data not shown). Thus, T * 2 correction of the AIF did not appear to influence the model fit in most cases, regardless of whether or not a T * 2 correction was applied to the LTIC. 
Discussion
The influence of T * 2 effect on lesion signal intensity and AIF can induce systematic errors in contrast kinetic parameter estimation, as previous studies [6, [17] [18] [19] [20] have shown. However, it has not been shown that T * 2 effect on contrast kinetic parameter estimation when a reference tissue approach is used where direct measurement of AIF is not feasible. In this study, we investigated the T * 2 effect in T 1 -weighted DCE-MRI experiments using a double-echo gradient echo sequence where pharmacokinetic parameter estimation was performed using a reference tissue AIF. The results of our study show that the difference between Method I (correction in both AIF and LTIC) and Method II (no correction) is quite small and could be negligible when K trans is small. As shown in Fig. 3 , four out of five animals with relatively low K trans (median value < 0.25 min
) showed no significant differences between Methods I and II. This suggests that T * 2 correction may not be necessary if K trans is small and a reference tissue AIF is used. On the other hand, mouse 2 and 5, whose median K trans values are relatively high (median value 0.59 and 0.45 min −1 respectively), showed significant differences between Methods I and II, which indicates that T * 2 effect is more apparent for higher K trans value. When T * 2 -correction was used for the AIF, but not for the LTIC (Method III), the estimated kinetic parameters were lower than those from the case with no correction (Method II) which is consistent with previous work using the directly measured AIF [6, 18] A previous study by de Bazelaire et al. [18] showed underestimations of peak arterial Gd concentration (>4 mM) by 59 ± 38 % among 18 patients due to the T * 2 effect. The underestimations were reduced by correction with T * 2 measurements. De Naeyer et al. [21] also showed that neglecting T * 2 could lead to errors of up to 43 % in arterial concentration estimation. In contrast, the corresponding underestimation of the AIF in our study ranged from 6.2 to 37.1 % with a mean of 21. in reference muscle tissue may be smaller than in direct arterial measurements. AIF underestimation resulted in substantial overestimation of K trans by 58 % in de Bazelaire et al. [18] and about 48 % in our current study.
One of the limitations of our study was that the contrast kinetic properties of the muscle (K trans = 0.11 min
and v e = 0.15) were assumed same for all animals. This assumption may not hold true in reality and could affect the estimation of the lesion contrast kinetic properties. However, the main object of this paper was to evaluate the relative changes in the contrast kinetic parameters due to the T * 2 effect, and we assumed that the effect from the variation in the muscle contrast kinetic properties is negligible. Future studies can include assessment of this assumption, along with employing more advanced techniques for reference tissue AIF [22, 23] . Double-gradient echo sequences have also been used in other studies for T * 2 correction [17, 24, 25] . Multiple gradient echo sequences with more than two echoes may help to improve the T * 2 estimation accuracy further and to also reduce the sensitivity to the selected TE, as shown by Zhuo et al. [26] , although acquisition of multiple gradient echoes decreases the temporal resolution, which is not favorable for contrast kinetic model analysis in general. Alternative approaches could be to estimate the AIF from phase measurements [27] , or by post-processing techniques based on transverse relaxivity of the MR contrast media [21] or shape of the vascular signal [28] . Further study is required to assess the feasibility of applying these techniques to DCE-MRI data analysis using a reference tissue AIF where the T * 2 effect is relatively small as shown in the present study.
One of the limitations of the current study was a small sample size (n = 7). Future studies are warranted to investigate the T * 2 effect with a larger cohort, as well as in DCE-MRI studies for monitoring tumors undergoing treatment that could induce changes in kinetic model parameters, thus affecting the influence of T * 2 correction. We used only two echoes to estimate T * 2 . More echoes can be used to measure T * 2 more accurately at the cost of increased sampling interval, which can also affect the estimation of kinetic parameters. The optimal selection of the number of echoes and sampling period needs to be investigated in future studies. Another limitation of this study was lack of comparison with the directly measured AIF, as it is not trivial to measure the AIF directly from an artery in mouse MRI due to the limited spatial resolution. A comparison of the T * 2 effect on a directly measured AIF versus a reference tissue AIF in the same subjects would provide useful insight into the role of a reference tissue AIF for reducing the effect of T * 2 in DCE-MRI studies.
It is not straightforward to generalize the findings in our study to other magnetic field strengths. Since T * 2 typically decreases with increase in the magnetic field strength, the degree of T * 2 effect on DCE-MRI can also be varied, depending on the magnetic field strength. However, we expect that the general trend will be similar; T * 2 effect on tumors with high K trans may not be negligible even if AIF is estimated from a reference tissue. This needs to be further investigated in future studies using different magnetic field strengths.
In this study, we investigated T * 2 effect on estimation of contrast kinetic model parameters using in vivo mouse DCE-MRI data. While such experimental data provide an opportunity to observe the realistic effect of T * 2 in a given experimental condition, it is also noted that there are short comings, including lack of ground truths, limited range of parameters, and limited flexibility to assess the association with the scan protocol. These limitations can be overcome in a numerical simulation study in which a wider range of parameters, and scan protocols based on the literature can be used. A future study is warranted to provide better understanding of the T * 2 effect in DCE-MRI in general.
Conclusion
In this study, we investigated the effect of T * 2 -correction of both reference tissue AIF and lesion signal intensity curve on contrast kinetic parameter estimation. Our results suggest that T * 2 effect on tumors with high K trans may not be negligible in kinetic model analysis, even if the AIF is estimated from a reference tissue where the concentration of contrast agent is relatively low. On the other hand, when K trans is small, it has been shown that T * 2 correction may not be necessary if a reference tissue AIF is used. 
